Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Fondaparinux vs Enoxaparin for VTE Prophylaxis in Medical ICU
NCT00493896Phase 3Terminated
- Sponsor
- Eastern Virginia Medical School
- Start
- Jul 2007
- Primary completion
- Apr 2010
- Modality
- Allosteric Modulators
01
Overview
Phase 3, randomised, double-blind trial of fondaparinux in venous thromboembolism (VTE) (2 arms), sponsored by Eastern Virginia Medical School. Primary endpoints: Bleeding events, Hemoglobin and 5 more. Started Jul 2007; status: terminated.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00493896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493896.